Assignee
TX MEDIC AB
SE·12 granted patents·9 pending applications·6 citations·filing 2013–2024
Top patents by PatentIndex Score
21 records- 0181US2024390412A1Use of dextran sulfateTX MEDIC AB·Filed 2024·Application pending·0 cites
- 0280US10730960B2Dextran sulfateTX MEDIC AB·Filed 2019·Granted Aug 4, 2020·1 cites·22 claims
- 0379US12076337B2Method for dissolving scars with dextran sulfateTX MEDIC AB·Filed 2022·Granted Sep 3, 2024·0 cites·14 claims
- 0476US8901104B2Use of dextran sulfateTX MEDIC AB·Filed 2013·Granted Dec 2, 2014·2 cites·28 claims
- 0573US10307440B2Use of dextran sulfateTX MEDIC AB·Filed 2016·Granted Jun 4, 2019·1 cites·17 claims
- 0673US9364499B2Use of dextran sulfateTX MEDIC AB·Filed 2013·Granted Jun 14, 2016·1 cites·11 claims
- 0771US11534457B2Use of dextran sulfateTX MEDIC AB·Filed 2018·Granted Dec 27, 2022·0 cites·17 claims
- 0867US10485817B2Use of dextran sulfate having an average molecular weight below 10000 DA for inducing angiogenesis in a subjectTX MEDIC AB·Filed 2015·Granted Nov 26, 2019·1 cites·15 claims
- 0964US10925890B2Use of dextran sulfateTX MEDIC AB·Filed 2019·Granted Feb 23, 2021·0 cites·16 claims
- 1063US2023126862A1Treatment of sepsis and hypercytokinemiaTX MEDIC AB·Filed 2021·Application pending·0 cites
- 1163US2023346827A1Treatment of coronavirus infectionsTX MEDIC AB·Filed 2021·Application pending·0 cites
- 1260US11291684B2Treatment of glaucomaTX MEDIC AB·Filed 2018·Granted Apr 5, 2022·0 cites·27 claims
- 1359US10478451B2Use of dextran sulfateTX MEDIC AB·Filed 2016·Granted Nov 19, 2019·0 cites·24 claims
- 1459US2024189343A1Treatment of virus infectionsTX MEDIC AB·Filed 2022·Application pending·0 cites
- 1557US2024165150A1Combination for treatment of thromboinflammationTX MEDIC AB·Filed 2022·Application pending·0 cites
- 1657US2024082296A1Treatment of muscle atrophy using dextran sulfateTX MEDIC AB·Filed 2021·Application pending·0 cites
- 1756US2023390324A1Treatment of fatty liver diseasesTX MEDIC AB·Filed 2021·Application pending·0 cites
- 1850US2022128542A1Treatment efficiency evaluationTX MEDIC AB·Filed 2020·Application pending·0 cites
- 1949US2022267728A1Allogenic car-t cell therapyTX MEDIC AB·Filed 2020·Application pending·0 cites
- 2043US10407514B2Dextran sulfateTX MEDIC AB·Filed 2015·Granted Sep 10, 2019·0 cites·16 claims
- 2133US10258642B2Dextran sulfate for use in mobilization of cellsTX MEDIC AB·Filed 2014·Granted Apr 16, 2019·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when TX MEDIC AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →